KalshiVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiCalibrazione approssimativaProbabilità implicita attualeBefore October 2027 90%In testa tra 5 esiti
Qualita del mercato
48 / 100
Bassa qualitàVolume 24h
0 €
Liquidità
6,5K €
Liquidità mediaBid / Ask
32.0% / 36.0%
Spread
4.0 pt
Spread moderatoDati di mercato
Aggiornato 13 minuti fa
16 mag 26, 2:301 gen 27, 4:59
Trend
Solo fondi simulati, nessun denaro realeNon è consulenza finanziaria
Esito scelto
Before Jan 1, 202736%
Trend del volume
$132 lug20g di dati27 lug
Mercati Correlati
Hantavirus pandemic in 2026?
98,4K €Sì: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
6,9K €26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
5,2K €Sì: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
2,4K €Above 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
2K €Sì: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
1,2K €Above 20k: 34%KALSHI
KALSHIAttivi in questi argomenti
Regole
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.